Results 151 to 160 of about 3,864 (165)

Acute cholecystitis as an adverse effect of treatment with elexacaftor/tezacaftor/ivacaftor in a patient with cystic fibrosis

Carlos Martín de Vicente, Silvia Jade Cáceres Barrera, Sánchez González, Cristina Alonso, Ruth García Romero   +4 more
openalex   +1 more source

Reported Adverse Events in Patients with CF Receiving Treatment with Elexacaftor/Tezacaftor/Ivacaftor: 5 Years Observational Study

Francesca Lucca, Ilaria Meneghelli, Gloria Tridello, Francesca Buniotto, Giulia Cucchetto, Sonia Volpi, Emily Pintani, Valentino Bezzerri, Marco Cipolli   +8 more
openalex   +2 more sources

Dried Blood Spot Method Development and Clinical Validation for the Analysis of Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, Ivacaftor, Ivacaftor Carboxylate, and Hydroxymethyl Ivacaftor Using LC-MS/MS

Steffie E. M. Vonk, Marloes van der Meer‐Vos, Renate Kos, Anne H. Neerincx, Suzanne W. J. Terheggen‐Lagro, Josje Altenburg, Anke H. Maitland‐van der Zee, Ron A. A. Mathôt, E. Marleen Kemper   +8 more
openalex   +1 more source

Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis [PDF]

Nidhi Patel, Maria Ansar, Anh Tuan Pham, Kelly Thomsen, Cameron J. McKinzie, Deepika Polineni, Charles R. Esther, Rebekah F. Brown   +7 more
openalex   +1 more source

Nutritional outcomes in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor: A 24-mo real-world study

Gianfranco Alicandro, Laura Zazzeron, Valentina Visciola, Anna Bulfamante, Arianna Biffi, Fabiola Corti, Andrea Gramegna, Francesco Blasi, Valeria Daccò   +8 more
openalex   +1 more source

Effect of elexacaftor-tezacaftor-ivacaftor therapy on systemic inflammation in people with cystic fibrosis

Viviane Mauro Corrêa Meyer1, Natália Aranha Netto1, Patricia Palmeira1, Rodrigo Abensur Athanazio2, Luiz Vicente Ribeiro Ferreira da Silva-Filho1   +4 more
openalex   +1 more source

Non-Tuberculous Mycobacterial Infection in Cystic Fibrosis Before and after Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Now is Not the Time to Lower the Guard

Ieuan Evans, Daniel J. Smıth, David W. Reid   +2 more
openalex   +1 more source

Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor/tezacaftor/ivacaftor: Findings from the promise study

Jennifer Duong, Hillary S. Hayden, Adrian J. Verster, Christopher E. Pope, Carson J. Miller, Kelsi Penewit, Stephen J. Salipante, Steven M. Rowe, George M. Solomon, David P. Nichols, Andrea Kelly, Sarah Jane Schwarzenberg, Steven D. Freedman, Lucas R. Hoffman   +13 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Elexacaftor/ivacaftor/tezacaftor

Reactions Weekly
  +27 more sources

Elexacaftor/ivacaftor/tezacaftor

Reactions Weekly, 2023
  +10 more sources